A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
Suppressing infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will probably require the rapid identification and isolation of individuals infected with the virus on an ongoing basis. Reverse-transcription polymerase chain reaction (RT-PCR) tests are accurate but costly, which makes the regular testing of every individual expensive. These costs are …